Al-`Aqar Healthcare REIT Annual Report 2020

AL-`AQAR HEALTHCARE REIT Annual Report 2020 78 PRINCIPLE A: BOARD LEADERSHIP AND EFFECTIVENESS (CONT’D) BOARD RESPONSIBILITIES (CONT’D) Anti-Bribery & Anti-Corruption Policy and Whistle Blowing Policy The Board also established and adopted the following policies which is available on the Fund’s website at www.alaqar.com.my: • Anti-Bribery and Anti-Corruption Policy; and • Whistle Blowing Policy. The above policies are made available to all Directors and employees and compliance is mandatory. The Board encourages all stakeholders to raise concerns or complaints under the Whistle Blowing Policy regarding any violation of the business conduct. The policies are reviewed periodically by the Board and revised as and when appropriate. BOARD COMPOSITION As of 31 December 2020, the Board comprised the following: • (1) Independent Non-Executive Chairman • (2) Independent Non-Executive Directors • (3) Non-Independent Non-Executive Directors • (1) Non-Independent Executive Director The Board take cognisance of the MCCG’s recommendation that at least half of the Board comprises Independent Directors. However, the Manager is governed by the Guidelines on Listed Real Estate Investment Trusts issued by the Securities Commission Malaysia and complied with Chapter 3.04 of the said guidelines which states that the Board must comprise at least two independent members, while maintaining a minimum ratio of at least one-third independent members at all times. Currently, the Board consists of three Independent Directors out of its seven members. During the year ended 31 December 2020, the Board convened five meetings and all Directors have complied with the required minimum of 50% attendance as required by Paragraph 15.05 of the Listing Requirements. The members of the Board and their attendances at Board meetings in 2020 are set out below: 55 th BOD 24 Feb 2020 Special BOD 8 Apr 2020 56 th BOD 28 May 2020 57 th BOD 27 Aug 2020 58 th BOD 24 Nov 2020 Dato’ Haji Mohd Redza Shah bin Abdul Wahid / / / / / Wan Azman bin Ismail / / / / / Zainah binti Mustafa / / / / / Dr. Mohd Hafetz bin Ahmad (1) / / / Dato’ Sr Dr. Rahah binti Ismail (2) / / / Dato’ Wan Kamaruzaman bin Wan Ahmad (3) / / Yusaini bin Haji Sidek (4) / / / / / Dato’ Amiruddin bin Abdul Satar (5) / / / Mohd Yusof bin Ahmad / / / / / Shamsul Anuar bin Abdul Majid (6) / / Notes: (1) Resigned w.e.f. 24 August 2020 (2) Resigned w.e.f. 24 August 2020 (3) Appointed w.e.f. 24 August 2020 (4) Resigned w.e.f. 15 January 2021 (5) Resigned w.e.f. 1 July 2020 (6) Appointed w.e.f. 24 August 2020 Corporate Governance Statement